Article
Supreme Court Of Canada Denies Merck Leave To Appeal From Decision Upholding Strict Interpretation Of Patent Listing Deadline
Merck sought leave to appeal a decision of the Federal Court of Appeal (2021 FCA 224) affirming a Federal Court decision upholding Health Canada's refusal to add a patent relating to a formulation of Merck's KEYTRUDA...

Smart & Biggar





